Clinical Trials Browser

Phase 2/3 × Temozolomide × Thoracic × Clear all

NCT03732482 2019-01-29

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Phase 2/3 Unknown

Non Small Cell Lung Cancer Metastatic